Importer of Controlled Substances Application: Organic Standards Solutions International, LLC, 13958-13959 [2019-06849]
Download as PDF
<![CDATA[
13958
Federal Register / Vol. 84, No. 67 / Monday, April 8, 2019 / Notices
Findings of Fact
jbell on DSK30RV082PROD with NOTICES
Respondent is the holder of DEA
Certificate of Registration No.
FW3352539, pursuant to which he is
authorized to dispense controlled
substances in schedules II through V as
a practitioner at the registered address
of Weingrow Wellness & Medical
Center, 7200 Smoke Ranch Road, Suite
#120, Las Vegas, Nevada. GX 2
(Certification of Registration History) to
Govt. Mot., at 1. This registration does
not expire until May 31, 2021. Id.
On July 25, 2018, the NSBP issued an
Order revoking Respondent’s Nevada
‘‘Controlled Substance Registration,
Certificate No. CS20272, and his
Practitioner Dispensing Registration,
Certificate No. PD00502,’’ effective July
18, 2018. GX 3 (July 25, 2018 Findings
of Fact, Conclusion of Law and Order of
the NSBP) to Govt. Mot., at 8. The
NSBP’s Order expressly prohibited
Respondent from, inter alia, (1)
‘‘prescrib[ing] any controlled substance
for any patient;’’ (2) ‘‘dispens[ing] any
controlled substance or dangerous
drug;’’ and (3) ‘‘possess[ing] any
controlled substance for office use or for
patient use.’’ Id. The NSBP also directed
Respondent to ‘‘immediately and
lawfully dispose of any and all
controlled substances in his possession
and/or control, other than a controlled
substance lawfully prescribed and
dispensed to him for his own personal
use.’’ Id.1 On September 10, 2018, the
NBME placed Respondent’s Nevada
medical license in an ‘‘[i]nactive status’’
as part of a Settlement Agreement
whereby Respondent agreed that his
medical license would be subject to
probation for 36 months and that he
would be prohibited from prescribing or
dispensing controlled substances during
that time. See GX 4 (NBME-Respondent
Settlement Agreement) to RFAA, at 5–
6. There is no evidence in the record
that the NSBP ever reinstated
Respondent’s Nevada controlled
substance or practitioner dispensing
registrations, nor is there any evidence
that the NBME changed the status of
1 After conducting a hearing, the NSBP based its
decision to revoke Respondent’s Nevada controlled
substance and practitioner dispensing registrations
in part on its finding that Respondent ‘‘routinely
permitted unlicensed members of his office staff
. . . to falsify his signature on the prescriptions for
medications dispensed by his medical office’’ and
‘‘to falsify patient initials and dates of service on
patients’ informed consent labels.’’ Id. at 1 & n.1,
2. The NSBP also found that Respondent
‘‘dispensed controlled substances and dangerous
drugs by mail to patients who live out-of-town’’ and
‘‘used Federal Express to ship medications to
patients.’’ Id. Respondent also signed a statement
agreeing to these fact findings. See id.
VerDate Sep<11>2014
17:45 Apr 05, 2019
Jkt 247001
Respondent’s medical license from
inactive status.
Accordingly, I find that Respondent
currently does not possess the authority
to dispense controlled substances in the
State of Nevada, the State in which he
is registered with the DEA, because both
the NSBP and the NBME have expressly
prohibited him from doing so.
Discussion
Pursuant to 21 U.S.C. 824(a)(3), the
Attorney General is authorized to
suspend or revoke a registration issued
under section 823 of the Controlled
Substances Act (CSA), ‘‘upon a finding
that the registrant . . . has had his State
license . . . suspended [or] revoked
. . . by competent State authority and is
no longer authorized by State law to
engage in the . . . dispensing of
controlled substances.’’ Also, DEA has
long held that the possession of
authority to dispense controlled
substances under the laws of the State
in which a practitioner engages in
professional practice is a fundamental
condition for obtaining and maintaining
a practitioner’s registration. See, e.g.,
James L. Hooper, 76 FR 71371 (2011),
pet. for rev. denied, 481 Fed. Appx. 826
(4th Cir. 2012); see also Frederick Marsh
Blanton, 43 FR 27616 (1978) (‘‘State
authorization to dispense or otherwise
handle controlled substances is a
prerequisite to the issuance and
maintenance of a Federal controlled
substances registration.’’).
This rule derives from the text of two
provisions of the CSA. First, Congress
defined ‘‘the term ‘practitioner’ [to]
mean[] a . . . physician . . . or other
person licensed, registered or otherwise
permitted, by . . . the jurisdiction in
which he practices . . . to distribute,
dispense, [or] administer . . . a
controlled substance in the course of
professional practice.’’ 21 U.S.C.
802(21). Second, in setting the
requirements for obtaining a
practitioner’s registration, Congress
directed that ‘‘[t]he Attorney General
shall register practitioners . . . if the
applicant is authorized to dispense . . .
controlled substances under the laws of
the State in which he practices.’’ 21
U.S.C. 823(f). Because Congress has
clearly mandated that a practitioner
possess state authority in order to be
deemed a practitioner under the Act,
DEA has long held that revocation of a
practitioner’s registration is the
appropriate sanction whenever he is no
longer authorized to dispense controlled
substances under the laws of the State
in which he engages in professional
practice. See, e.g., Calvin Ramsey, 76 FR
20034, 20036 (2011); Sheran Arden
Yeates, M.D., 71 FR 39130, 39131
PO 00000
Frm 00097
Fmt 4703
Sfmt 4703
(2006); Dominick A. Ricci, 58 FR 51104,
51105 (1993); Bobby Watts, 53 FR
11919, 11920 (1988); Blanton, 43 FR
27616 (1978).
Here, I find that there is no dispute
over the material fact that Respondent is
no longer currently authorized to
dispense controlled substances in
Nevada, the State in which he is
registered with the Agency.
Accordingly, Respondent is not entitled
to maintain his DEA registration. I will
therefore adopt the ALJ’s
recommendation that I revoke
Respondent’s registration. R.D., at 5. I
will also deny any pending application
to renew or to modify his registration,
or any pending application for any other
DEA registration in Nevada.
Order
Pursuant to the authority vested in me
by 21 U.S.C. 823(f) and 824(a), as well
as 28 CFR 0.100(b), I order that DEA
Certificate of Registration No.
FW3352539, issued to Craig M.
Weingrow, M.D., be, and it hereby is,
revoked. I further order that any
pending application of Craig M.
Weingrow to renew or modify the above
registration, or any pending application
of Craig M. Weingrow for any other DEA
registration in the State of Nevada, be,
and it hereby is, denied. This Order is
effective immediately.2
Dated: March 22, 2019.
Uttam Dhillon,
Acting Administrator.
[FR Doc. 2019–06834 Filed 4–5–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Organic Standards
Solutions International, LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 8, 2019. Such persons
may also file a written request for a
hearing on the application on or before
May 8, 2019.
DATES:
2 For the same reasons which led the NSBP to
revoke Respondent’s controlled substances and
practitioner’s dispensing licenses and prescriptive
authority, I conclude that the public interest
necessitates that this Order be effective
immediately. 21 CFR 1316.67.
E:\FR\FM\08APN1.SGM
08APN1
13959
Federal Register / Vol. 84, No. 67 / Monday, April 8, 2019 / Notices
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on June
21, 2017, Organic Standards Solutions
International, LLC, 2030 Savage Road,
Charleston, South Carolina 29407–2940
applied to be registered as an importer
of the following basic classes of
controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled
substance
Drug code
jbell on DSK30RV082PROD with NOTICES
Marihuana Extract
Marihuana ..............
Tetrahydrocannabinols.
7350
7360
7370
Schedule
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
BILLING CODE 4410–09–P
Jkt 247001
Notice of registration.
The registrant listed below
has applied for and been granted a
registration by the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of schedule II controlled
substances.
SUMMARY:
The
company listed below applied to be
registered as a bulk manufacturer of
schedule II controlled substances.
Information on the previously published
notice is listed in the table below. No
comments or objections were submitted
for this notice.
SUPPLEMENTARY INFORMATION:
Company
FR docket
Cambrex High Point,
Inc.
83 FR 64159
Published
December 13, 2018.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of this registrant to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed company.
registration by the Drug Enforcement
Administration (DEA) as importers of
schedule I or schedule II controlled
substances.
SUPPLEMENTARY INFORMATION: The
companies listed below applied to be
registered as importers of various basic
classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for a hearing were
submitted for these notices.
Company
Chattem Chemicals ..
Research Triangle Institute.
FR docket
84 FR 2578
84 FR 2571
Published
February 7, 2019.
February 7, 2019.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable basic classes of schedule I or
II controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each of the company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or schedule II controlled
substances to the above listed
companies.
Dated: March 21, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–06842 Filed 4–5–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
BILLING CODE 4410–09–P
[Docket No. DEA–392]
DEPARTMENT OF JUSTICE
Importer of Controlled Substances
Registration
Drug Enforcement Administration
ACTION:
[Docket No. DEA–392]
SUMMARY:
Importer of Controlled Substances
Registration
ACTION:
[FR Doc. 2019–06849 Filed 4–5–19; 8:45 am]
17:45 Apr 05, 2019
[Docket No. DEA–392]
[FR Doc. 2019–06844 Filed 4–5–19; 8:45 am]
The company plans to import the
listed controlled substances to produce
analytical reference standards for
distribution to its customers. Drug codes
7350 (marihuana extract) and 7360
(marihuana) will be used for the
manufacture of cannabidiol only.
VerDate Sep<11>2014
Drug Enforcement Administration
Dated: March 21, 2019.
John J. Martin,
Assistant Administrator.
I
I
I
Dated: March 21, 2019.
John J. Martin,
Assistant Administrator.
DEPARTMENT OF JUSTICE
Notice of registration.
The registrants listed below
have applied for and been granted
SUMMARY:
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
Notice of registration.
The registrant listed below
has applied for and been granted a
registration by the Drug Enforcement
Administration (DEA) as an importer of
schedule II controlled substances.
SUPPLEMENTARY INFORMATION: The
company listed below applied to be
registered as an importer of various
E:\FR\FM\08APN1.SGM
08APN1
]]>Agencies
[Federal Register Volume 84, Number 67 (Monday, April 8, 2019)]
[Notices]
[Pages 13958-13959]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06849]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Organic Standards
Solutions International, LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before May 8, 2019. Such
persons may also file a written request for a hearing on the
application on or before May 8, 2019.
[[Page 13959]]
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on June
21, 2017, Organic Standards Solutions International, LLC, 2030 Savage
Road, Charleston, South Carolina 29407-2940 applied to be registered as
an importer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Marihuana Extract.................... 7350 I
Marihuana............................ 7360 I
Tetrahydrocannabinols................ 7370 I
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
produce analytical reference standards for distribution to its
customers. Drug codes 7350 (marihuana extract) and 7360 (marihuana)
will be used for the manufacture of cannabidiol only.
Dated: March 21, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-06849 Filed 4-5-19; 8:45 am]
BILLING CODE 4410-09-P
